Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide

E. S. Kleinerman, K. L. Erickson, A. J. Schroit, W. E. Fogler, I. J. Fidler

Research output: Contribution to journalArticle

129 Scopus citations

Abstract

Peripheral blood monocytes were isolated from normal human donors by separation on a continuous Percoll gradient and adherence to yield preparations of blood monocytes with a high degree of purity (> 99%). The monocytes were incubated in vitro with medium alone or with multilamellar liposomes that contained either a lipophilic derivative of muramyl dipeptide, muramyl tripeptide (MTP-PE), or medium. The cytotoxic properties of the monocytes were assessed by an in vitro radioisotope release assay against various allogeneic targets. Monocytes that have phagocytosed liposomes containing MTP-PE were rendered tumoricidal. These monocytes lysed cells of three different tumorigenic lines but not cells of two nontumorigenic lines. The ability of MTP-PE-activated human blood monocytes to recognize and selectively lyse neoplastic cells was also demonstrated under cocultivation conditions. We conclude that human blood monocytes can be rendered tumoricidal after interaction with liposomes containing MTP-PE.

Original languageEnglish (US)
Pages (from-to)2010-2014
Number of pages5
JournalCancer Research
Volume43
Issue number5
StatePublished - May 1 1983

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide'. Together they form a unique fingerprint.

  • Cite this

    Kleinerman, E. S., Erickson, K. L., Schroit, A. J., Fogler, W. E., & Fidler, I. J. (1983). Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide. Cancer Research, 43(5), 2010-2014.